<SEC-DOCUMENT>9999999995-24-000271-index.html : 20240201
<SEC-HEADER>9999999995-24-000271.hdr.sgml : 20240201
<ACCEPTANCE-DATETIME>20240201001524
ACCESSION NUMBER:		9999999995-24-000271
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240201
EFFECTIVENESS DATE:		20240131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BriaCell Therapeutics Corp.
		CENTRAL INDEX KEY:			0001610820
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276650
		FILM NUMBER:		24584885

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1
		BUSINESS PHONE:		(604) 921-1810

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ansell Capital Corp.
		DATE OF NAME CHANGE:	20140613
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>